{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:36:09Z","timestamp":1791218169100,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1053\/pcad.2002.128449","type":"journal-article","created":{"date-parts":[[2002,10,31]],"date-time":"2002-10-31T17:40:59Z","timestamp":1036086059000},"page":"115-128","source":"Crossref","is-referenced-by-count":43,"title":["Primary pulmonary hypertension: Current therapy"],"prefix":"10.1053","volume":"45","author":[{"given":"Olivier","family":"Sitbon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/pcad.2002.128449_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective study","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib4","author":"Rich"},{"key":"10.1053\/pcad.2002.128449_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(98)02111-4","article-title":"Primary pulmonary hypertension","volume":"352","author":"Gaine","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/pcad.2002.128449_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0272-5231(05)70288-4","article-title":"Medical therapy of pulmonary hypertension. Conventional therapies","volume":"22","author":"Naeije","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1053\/pcad.2002.128449_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.69.2.143","article-title":"Pulmonary hypertension in patients using oral contraceptives","volume":"69","author":"Kleiger","year":"1976","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0025-6196(12)65277-X","article-title":"Primary pulmonary hypertension: A histopathological study of 80 cases","volume":"60","author":"Bjornsson","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/pcad.2002.128449_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/01.CIR.80.5.1207","article-title":"Primary pulmonary hypertension. Vascular structure, morphometry and responsiveness to vasodilators agents","volume":"80","author":"Palevsky","year":"1989","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: Natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib13","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1378\/chest.105.2_Supplement.33S","article-title":"Primary pulmonary hypertension: Case series from France","volume":"105","author":"Brenot","year":"1994","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1172\/JCI109542","article-title":"Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease","volume":"64","author":"Dantzker","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1053\/pcad.2002.128449_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","article-title":"The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(84)90783-6","article-title":"Raynaud's phenomenon of the lung","volume":"76","author":"Fahey","year":"1984","journal-title":"Am J Med"},{"key":"10.1053\/pcad.2002.128449_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/ajrccm.151.2.7842196","article-title":"Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin","volume":"151","author":"Sitbon","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09031936.98.12020265","article-title":"Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension","volume":"12","author":"Sitbon","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1053\/pcad.2002.128449_bib19","first-page":"342","article-title":"The case for treatment of selected patients with primary pulmonary hypertension","volume":"134","author":"Reeves","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/pcad.2002.128449_bib20","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.93.3.484","article-title":"Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension","volume":"93","author":"Raffy","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0735-1097(98)00361-1","article-title":"Inhaled nitric oxide in primary pulmonary hypertension: A safe and effective agent for predicting response to nifedipine","volume":"32","author":"Ricciardi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.66.2.334","article-title":"Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension","volume":"66","author":"Rubin","year":"1982","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib24","first-page":"A223","article-title":"Detection of a reversible component in primary pulmonary hypertension: Value of prostacyclin acute infusion","volume":"133","author":"Simonneau","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/pcad.2002.128449_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.84.3.1145","article-title":"Adenosine as a vasodilator in primary pulmonary hypertension","volume":"84","author":"Morgan","year":"1991","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0735-1097(92)90295-X","article-title":"Comparison of the effects of adenosine and nifedipine in pulmonary hypertension","volume":"19","author":"Schrader","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1378\/chest.107.1.54","article-title":"Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension","volume":"107","author":"Nootens","year":"1995","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/pcad.2002.128449_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thx.52.4.369","article-title":"Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: Predictive-ability and consequences on haemodynamics and gas exchange","volume":"52","author":"Jolliet","year":"1997","journal-title":"Thorax"},{"key":"10.1053\/pcad.2002.128449_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.119.1.128","article-title":"Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension","volume":"119","author":"Cockrill","year":"2001","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0735-1097(99)00494-5","article-title":"A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group","volume":"35","author":"Hoeper","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib32","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1378\/chest.93.3_Supplement.179S","article-title":"Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension","volume":"93","author":"Palevsky","year":"1988","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib33","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/01.CIR.82.6.2018","article-title":"Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension","volume":"82","author":"Palevsky","year":"1990","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","article-title":"Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation","volume":"78","author":"Frostell","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1053\/pcad.2002.128449_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.101.3.325","article-title":"Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO\/PPHN Study Group","volume":"101","author":"Davidson","year":"1998","journal-title":"Pediatrics"},{"key":"10.1053\/pcad.2002.128449_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.87.2.447","article-title":"Inhaled nitric oxide in congenital heart disease","volume":"87","author":"Roberts","year":"1993","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000542-199211000-00007","article-title":"Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension","volume":"77","author":"Girard","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1053\/pcad.2002.128449_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199302113280605","article-title":"Inhaled nitric oxide for the adult respiratory distress syndrome","volume":"328","author":"Rossaint","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1164\/ajrccm\/148.2.310","article-title":"Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension","volume":"148","author":"Adnot","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/pcad.2002.128449_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","article-title":"Oral hydralazine therapy for primary pulmonary hypertension","volume":"302","author":"Rubin","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-103-2-258","article-title":"Vasodilator therapy for primary pulmonary hypertension","volume":"103","author":"Packer","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00005792-198601000-00004","article-title":"Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature","volume":"65","author":"Hughes","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/pcad.2002.128449_bib43","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM198206033062203","article-title":"Deleterious effects of hydralazine in patients with pulmonary hypertension","volume":"306","author":"Packer","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0025-6196(12)62055-2","article-title":"Vasodilator therapy for primary pulmonary hypertension","volume":"59","author":"McGoon","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/pcad.2002.128449_bib45","doi-asserted-by":"crossref","first-page":"196B","DOI":"10.1016\/0002-9149(85)90631-9","article-title":"Therapeutic application of calcium-channel antagonists for pulmonary hypertension","volume":"55","author":"Packer","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/hrt.52.1.106","article-title":"Detrimental effects of verapamil in patients with primary pulmonary hypertension","volume":"52","author":"Packer","year":"1984","journal-title":"Br Heart J"},{"key":"10.1053\/pcad.2002.128449_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/hrt.75.2.171","article-title":"Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension","volume":"75","author":"Woodmansey","year":"1996","journal-title":"Heart"},{"key":"10.1053\/pcad.2002.128449_bib48","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1001\/jama.284.24.3160","article-title":"Pulmonary hypertension","volume":"284","author":"Gaine","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/pcad.2002.128449_bib49","first-page":"115","article-title":"Prostacyclin","author":"Jones","year":"1996"},{"key":"10.1053\/pcad.2002.128449_bib50","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"a. Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib52","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(84)91452-1","article-title":"Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)","volume":"1","author":"Higenbottam","year":"1984","journal-title":"Lancet"},{"key":"10.1053\/pcad.2002.128449_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","article-title":"Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion","volume":"30","author":"Shapiro","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/hrt.80.2.151","article-title":"Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension","volume":"80","author":"Higenbottam","year":"1998","journal-title":"Heart"},{"key":"10.1053\/pcad.2002.128449_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib60","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in Primary Pulmonary Hypertension: Prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib61","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1378\/chest.114.5.1269","article-title":"A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension","volume":"114","author":"Robbins","year":"1998","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib62","first-page":"679","article-title":"The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation","volume":"17","author":"Conte","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/pcad.2002.128449_bib63","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0735-1097(99)00320-4","article-title":"The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension","volume":"34","author":"Rich","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib64","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib65","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1148\/radiol.2223010668","article-title":"Pulmonary arterial hypertension: Thin-section CT predictors of epoprostenol therapy failure","volume":"222","author":"Resten","year":"2002","journal-title":"Radiology"},{"key":"10.1053\/pcad.2002.128449_bib66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib67","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: Results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1053\/pcad.2002.128449_bib68","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib69","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/pcad.2002.128449_bib70","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/pcad.2002.128449_bib71","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib72","first-page":"A412","article-title":"Declining mortality from HIV-associated pulmonary arterial hypertension with combined use of highly active antiretroviral therapy and long-term epoprostenol infusion","volume":"165","author":"Nunes","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib73","first-page":"890","article-title":"Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades","volume":"48","author":"Jones","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1053\/pcad.2002.128449_bib74","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/ajrcmb.17.6.2888","article-title":"Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and in rat lung via cAMP","volume":"17","author":"Hoeper","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1053\/pcad.2002.128449_bib75","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1164\/ajrccm.165.3.2106033","article-title":"Improvement of the pressure flow relationships of the pulmonary circulation in primary pulmonary hypertension after six weeks prostacyclin","volume":"165","author":"Castelain","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/pcad.2002.128449_bib76","first-page":"448","article-title":"Experimental studies of the surgical treatment of primary pulmonary hypertension","volume":"48","author":"Austen","year":"1964","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/pcad.2002.128449_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/hrt.55.5.449","article-title":"Factors that influence the outcome of primary pulmonary hypertension","volume":"55","author":"Rozkovec","year":"1986","journal-title":"Br Heart J"},{"key":"10.1053\/pcad.2002.128449_bib78","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1378\/chest.91.5.675","article-title":"Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation","volume":"91","author":"Glanville","year":"1987","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib79","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/0002-9149(83)90678-1","article-title":"Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension","volume":"51","author":"Rich","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1053\/pcad.2002.128449_bib80","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/01.CIR.91.7.2028","article-title":"Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension","volume":"91","author":"Kerstein","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/pcad.2002.128449_bib81","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0272-5231(05)70291-4","article-title":"Atrial septostomy for pulmonary hypertension","volume":"22","author":"Sandoval","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1053\/pcad.2002.128449_bib82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM198203113061001","article-title":"Heart-lung transplantation: Successful therapy for patients with pulmonary vascular disease","volume":"306","author":"Reitz","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1053\/pcad.2002.128449_bib83","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1378\/chest.98.5.1107","article-title":"Single lung transplantation for primary pulmonary hypertension","volume":"98","author":"Levine","year":"1990","journal-title":"Chest"},{"key":"10.1053\/pcad.2002.128449_bib84","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1053-2498(01)00323-0","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 18th Official Report\u20142001","volume":"20","author":"Hosenpud","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/pcad.2002.128449_bib85","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-5231(05)70293-8","article-title":"Lung transplantation for primary pulmonary hypertension","volume":"22","author":"Trulock","year":"2001","journal-title":"Clin Chest Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062002700029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062002700029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T15:23:03Z","timestamp":1554391383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062002700029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0033062002700029"],"URL":"https:\/\/doi.org\/10.1053\/pcad.2002.128449","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}